Ran Yu

1.4k total citations · 1 hit paper
35 papers, 1.1k citations indexed

About

Ran Yu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ran Yu has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Ran Yu's work include Wound Healing and Treatments (4 papers), Digestive system and related health (3 papers) and Chemotherapy-related skin toxicity (3 papers). Ran Yu is often cited by papers focused on Wound Healing and Treatments (4 papers), Digestive system and related health (3 papers) and Chemotherapy-related skin toxicity (3 papers). Ran Yu collaborates with scholars based in China, Japan and United States. Ran Yu's co-authors include Lili Chen, Jiajia Zhao, Hu Li, Handong Zhang, Huang Fang, Juan Wang, Xin Zhou, Kaifang Zou, Manabu Fujimoto and Guihua Jin and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Annals of Oncology.

In The Last Decade

Ran Yu

33 papers receiving 1.1k citations

Hit Papers

Exosomes derived from human adipose mensenchymal stem cel... 2016 2026 2019 2022 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Yu China 14 555 258 221 177 104 35 1.1k
Ahmed T. El‐Serafi Egypt 18 342 0.6× 91 0.4× 101 0.5× 139 0.8× 98 0.9× 61 913
Ileana Ruxandra Botusan Sweden 16 453 0.8× 393 1.5× 163 0.7× 315 1.8× 182 1.8× 21 1.3k
Kuo Shen China 16 689 1.2× 289 1.1× 167 0.8× 242 1.4× 107 1.0× 39 1.3k
Zhao Zheng China 22 629 1.1× 412 1.6× 214 1.0× 233 1.3× 209 2.0× 46 1.4k
Laura Bertoni Italy 23 396 0.7× 52 0.2× 315 1.4× 81 0.5× 304 2.9× 70 1.5k
Marjolaine Gosset France 18 684 1.2× 43 0.2× 87 0.4× 269 1.5× 248 2.4× 49 1.9k
Xue Yuan United States 27 939 1.7× 28 0.1× 166 0.8× 107 0.6× 225 2.2× 65 2.0k
Hongwei Liu China 21 317 0.6× 368 1.4× 338 1.5× 90 0.5× 306 2.9× 94 1.4k
Dimitrios Baltzis United States 9 157 0.3× 548 2.1× 105 0.5× 29 0.2× 121 1.2× 15 1.0k
Joshua Tam United States 15 384 0.7× 167 0.6× 313 1.4× 66 0.4× 327 3.1× 46 1.3k

Countries citing papers authored by Ran Yu

Since Specialization
Citations

This map shows the geographic impact of Ran Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Yu more than expected).

Fields of papers citing papers by Ran Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Yu. The network helps show where Ran Yu may publish in the future.

Co-authorship network of co-authors of Ran Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Yu. A scholar is included among the top collaborators of Ran Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Yu. Ran Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yuting, Yaqing Li, Zhen Kong, et al.. (2025). Uncovering the Associations of LILRB4 Genotypes With Parkinson's Disease: From Clinical Traits to Potential Pathologies. CNS Neuroscience & Therapeutics. 31(7). e70522–e70522.
2.
Xiao, Yao, et al.. (2025). N6-methyladenosine regulators in inflammatory bowel disease. Biochemical and Biophysical Research Communications. 784. 152660–152660.
3.
Zhang, Lei, et al.. (2024). Development and validation of a risk prediction model and prediction tools for post-thrombotic syndrome in patients with lower limb deep vein thrombosis. International Journal of Medical Informatics. 187. 105468–105468. 1 indexed citations
4.
Zuo, Zhi, Ran Yu, Yao Xiao, et al.. (2023). Berberine ameliorates contrast‐induced acute kidney injury by regulating HDAC4‐FoxO3a axis‐induced autophagy: In vivo and in vitro. Phytotherapy Research. 38(4). 1761–1780. 12 indexed citations
6.
Yu, Ran, et al.. (2023). The clinical predictive value and regulation mechanism of microRNA-188-5p in contrast-induced acute kidney injury. Biochemical and Biophysical Research Communications. 679. 215–223. 5 indexed citations
7.
Li, Cheng, et al.. (2022). Association between Porphyromonas Gingivalis and systemic diseases: Focus on T cells-mediated adaptive immunity. Frontiers in Cellular and Infection Microbiology. 12. 1026457–1026457. 27 indexed citations
8.
Wang, Wanpeng, et al.. (2021). Integrated transcriptomics explored the cancer-promoting genes CDKN3 in esophageal squamous cell cancer. Journal of Cardiothoracic Surgery. 16(1). 148–148. 6 indexed citations
9.
Zhang, Jiaqi, Mengru Xie, Xiaofei Huang, et al.. (2021). The Effects of Porphyromonas gingivalis on Atherosclerosis-Related Cells. Frontiers in Immunology. 12. 766560–766560. 59 indexed citations
10.
Yu, Ran, Guihua Jin, & Manabu Fujimoto. (2021). Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases. Frontiers in Oncology. 11. 722331–722331. 42 indexed citations
11.
Fujimoto, Manabu, Fangfang Li, Ran Yu, et al.. (2021). Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23/Th17 Axis. Frontiers in Pharmacology. 12. 704481–704481. 16 indexed citations
12.
Wang, Wanpeng, et al.. (2021). Expression and clinical significance of B cell translocation gene 2 in esophageal squamous cell carcinoma.. PubMed. 14(4). 475–483. 1 indexed citations
13.
Yu, Ran, et al.. (2020). Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma. Frontiers in Genetics. 11. 796–796. 6 indexed citations
14.
15.
Liu, Xiaojing, Ran Yu, & Kaifang Zou. (2019). Probiotic Mixture VSL#3 Alleviates Dextran Sulfate Sodium-induced Colitis in Mice by Downregulating T Follicular Helper Cells. Current Medical Science. 39(3). 371–378. 31 indexed citations
16.
Zhou, Xin, Ran Yu, Yanlin Long, et al.. (2018). BMAL1 deficiency promotes skeletal mandibular hypoplasia via OPG downregulation. Cell Proliferation. 51(5). e12470–e12470. 39 indexed citations
17.
Liu, Xiaojing, Ran Yu, Liangru Zhu, Xiaohua Hou, & Kaifang Zou. (2017). Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 23(10). 1741–1751. 64 indexed citations
18.
Zhao, Jiajia, Xin Zhou, Qingming Tang, et al.. (2017). BMAL1 Deficiency Contributes to Mandibular Dysplasia by Upregulating MMP3. Stem Cell Reports. 10(1). 180–195. 33 indexed citations
19.
Chen, Lili, Jiajia Zhao, Qingming Tang, et al.. (2016). PFKFB3 Control of Cancer Growth by Responding to Circadian Clock Outputs. Scientific Reports. 6(1). 24324–24324. 28 indexed citations
20.
Yu, Ran, Gang Chen, Chunju Zhou, et al.. (2012). Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomas. Leukemia Research. 36(9). 1141–1146. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026